Recombinant Human ADAR Protein，His

ADAR proteins, or Adenosine Deaminases Acting on RNA, are crucial enzymes involved in the editing of RNA molecules, specifically converting adenosine (A) into inosine (I) in double-stranded RNA (dsRNA). This post-transcriptional modification plays significant roles in various biological processes, including the regulation of gene expression, the immune response, and the generation of protein diversity. ADAR proteins are particularly important in the context of neurological function and are implicated in numerous diseases, including viral infections and neurodegenerative disorders. Research has shown that abnormalities in ADAR activity can lead to dysregulation of RNA editing, contributing to conditions such as cancer and autoimmune diseases. The study of ADAR proteins and their mechanisms is vital for understanding their multifaceted roles in cellular physiology and disease pathology. Researchers are increasingly focused on the therapeutic potential of targeting ADAR activity, either by enhancing or inhibiting its function, to develop innovative treatments for these conditions. As the molecular characterization of ADAR proteins progresses, there is a growing interest in their application in gene therapy, precision medicine, and the development of RNA-based therapeutics. This unique RNA editing capability positions ADAR proteins as promising tools in biotechnology, further driving research into their structure, function, and regulation in various biological contexts.